The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Negotiation of long term lease and development agreement for an international hotel company
Represented an international hotel company in the negotiation of long term lease of condominium unit in multi-use high rise building on historic more
Employment litigation for one of the largest U.S. forest products manufacturers
Successfully defended one of the largest U.S. forest products manufacturers against a former employee's allegations that his termination constituted more
Trademark infringement for a Fortune 500 multinational computer software manufacturer
Successfully represented a Fortune 500 multinational corporation that designs and manufactures consumer electronics and computer software more
Antitrust counseling to actuarial firms' captive insurance company
The firm has served for many years as antitrust counsel to a captive insurance company comprised of three competitor members. more